Commonwealth Equity Services, Inc - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$38,000
-62.7%
30,392
-8.1%
0.00%
-100.0%
Q1 2017$102,000
-29.2%
33,075
-6.0%
0.00%0.0%
Q4 2016$144,000
-38.7%
35,175
-4.8%
0.00%
-50.0%
Q3 2016$235,000
+30.6%
36,931
+10.5%
0.00%0.0%
Q2 2016$180,000
-40.0%
33,431
-6.8%
0.00%
-33.3%
Q1 2016$300,000
+7.9%
35,881
+1.9%
0.00%0.0%
Q4 2015$278,000
-5.4%
35,216
+2.0%
0.00%0.0%
Q3 2015$294,000
-13.8%
34,515
+25.2%
0.00%0.0%
Q2 2015$341,000
+76.7%
27,565
+69.9%
0.00%
+50.0%
Q1 2015$193,00016,2250.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 775,571$2,389,0000.93%
KEMPNER CAPITAL MANAGEMENT INC. 148,985$459,0000.31%
Yakira Capital Management, Inc. 248,420$765,0000.27%
GARRISON BRADFORD & ASSOCIATES INC 87,700$270,0000.24%
Cannell & Co. 1,212,478$3,734,0000.13%
LeJeune Puetz Investment Counsel LLC 3,976$180,0000.13%
ALPINE WOODS CAPITAL INVESTORS, LLC 726,000$2,236,0000.12%
Virtus ETF Advisers LLC 198,735$612,0000.11%
STONERIDGE INVESTMENT PARTNERS LLC 199,227$614,0000.08%
Birchview Capital, LP 44,000$136,0000.08%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders